Dun-Chang Mo

12PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 05, 2022
Efficacy of immune checkpoint inhibitor as maintenance therapy for advanced or metastatic cancers: A meta-analysis of randomized controlled trials.

Dun-Chang Mo, Jian-Feng Huang, Peng-Hui Luo

|Jul 30, 2022
PD-1/PD-L1 inhibitor plus chemotherapy versus standard of care in the first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma.

Dun-Chang Mo, Jian-Feng Huang, Peng-Hui Luo

Pageof 2

Frequent Collaborators

1 joint publications

Ji-Gan Wang

1 joint publications

Lang Qin

1 joint publications

Tao Ren

1 joint publications

Jian-Feng Huang